JPH0528720B2 - - Google Patents

Info

Publication number
JPH0528720B2
JPH0528720B2 JP60037333A JP3733385A JPH0528720B2 JP H0528720 B2 JPH0528720 B2 JP H0528720B2 JP 60037333 A JP60037333 A JP 60037333A JP 3733385 A JP3733385 A JP 3733385A JP H0528720 B2 JPH0528720 B2 JP H0528720B2
Authority
JP
Japan
Prior art keywords
benzyl
title product
mol
dioxide
benzyloxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60037333A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60202889A (ja
Inventor
Aanesuto Baasu Uein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS60202889A publication Critical patent/JPS60202889A/ja
Publication of JPH0528720B2 publication Critical patent/JPH0528720B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/861—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hydrocarbon radical or a substituted hydrocarbon radical, directly attached in position 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP60037333A 1984-02-27 1985-02-26 β‐ラクタマーゼ阻害剤としての６‐（アミノアシルオキシメチル）ペニシラン酸１，１‐ジオキシド誘導体 Granted JPS60202889A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US584044 1984-02-27
US06/584,044 US4503040A (en) 1984-02-27 1984-02-27 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors

Publications (2)

Publication Number Publication Date
JPS60202889A JPS60202889A (ja) 1985-10-14
JPH0528720B2 true JPH0528720B2 (enExample) 1993-04-27

Family

ID=24335687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60037333A Granted JPS60202889A (ja) 1984-02-27 1985-02-26 β‐ラクタマーゼ阻害剤としての６‐（アミノアシルオキシメチル）ペニシラン酸１，１‐ジオキシド誘導体

Country Status (6)

Country Link
US (1) US4503040A (enExample)
EP (1) EP0154444A1 (enExample)
JP (1) JPS60202889A (enExample)
DK (1) DK86085A (enExample)
GR (1) GR850465B (enExample)
IE (1) IE850475L (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4797394A (en) * 1985-10-29 1989-01-10 Pfizer Inc. 6-(1-carbamoyl-1-hydroxymethyl)penicillanic acid derivatives
US4868296A (en) * 1985-10-29 1989-09-19 Pfizer Inc. 6-(1-carbamoyl-1-hydroxymethyl) penicillanic acid derivatives
US4826817A (en) * 1986-02-07 1989-05-02 Brown Thomas E Amino acid and hydroxyamino acid transporter compounds for therapeutic applications, process and use
US4782050A (en) * 1987-01-27 1988-11-01 Pfizer Inc. 6-beta(substituted)-(S)-hydroxymethylpenicillanic acids and derivatives thereof
US5049384A (en) * 1988-07-08 1991-09-17 Kim Young S Antibacterial composition for medical use and a process for the preparation thereof
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
AU6682796A (en) 1995-07-21 1997-02-18 New York University Type ii phospholipase a2 and its use in killing gram-positive bacteria
US6103765A (en) * 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
EP1005336A4 (en) 1997-07-09 2001-01-17 Androsolutions Inc IMPROVED METHODS AND COMPOSITIONS FOR TREATING MALE ERECTIONAL DISORDERS
US6395726B1 (en) 1999-01-26 2002-05-28 American Cyanamid Company 3,6-disubstituted penam sulfone derivatives
HUP0200013A3 (en) * 1999-01-26 2002-10-28 American Cyanamid Co Madison 3,6-disubstituted penam sulfone derivatives, process for their preparation and pharmaceutical compositions containing them
WO2001040228A1 (en) * 1999-12-03 2001-06-07 Kyoto Pharmaceutical Industries, Ltd. Carbapenem compounds, use of the same and intermediates thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272439A (en) * 1978-06-02 1981-06-09 Schering Corporation 6-(Substituted-hydroxymethylene penams)
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
US4342768A (en) * 1979-10-22 1982-08-03 Pfizer Inc. Bis-esters of 1,1-alkanediols with 6-beta-hydroxymethylpenicillanic acid 1,1-dioxide and beta-lactam antibiotics
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
EP0083977A1 (en) * 1982-01-11 1983-07-20 Pfizer Inc. 6-Alpha-hydroxymethylpenicillanic acid sulfone as a beta-lactamase inhibitor
GB2113681A (en) * 1982-01-26 1983-08-10 Leo Pharm Prod Ltd B-lactam antibiotics
DE3302335A1 (de) * 1982-01-26 1983-07-28 Leo Pharmaceutical Products Ltd. A/S (Loevens kemiske Fabrik Produktionsaktieselskab), 2750 Ballerup Ss-lactamverbindungen, ihre herstellung und sie enthaltendes arzneimittel

Also Published As

Publication number Publication date
EP0154444A1 (en) 1985-09-11
JPS60202889A (ja) 1985-10-14
US4503040A (en) 1985-03-05
IE850475L (en) 1985-08-27
GR850465B (enExample) 1985-06-21
DK86085D0 (da) 1985-02-26
DK86085A (da) 1985-08-28

Similar Documents

Publication Publication Date Title
KR830001903B1 (ko) 페니실란산유도체의 제조방법
EP0199446B1 (en) Penem compounds, production and use thereof
JPH0528720B2 (enExample)
AU674768B2 (en) 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors
US8258321B2 (en) Beta-lactone compounds
DE69610145T2 (de) Benzo-kondensierte Azepinon-und Piperidinonverbindungen, nützlich als ACE-und NEP-Inhibitoren
NO802686L (no) Fremgangsmaate for fremstilling av en ester av et klavulansyreamin
CA1339450C (en) Stable oxapenem-3-carboxylic acids
EP0850230A1 (en) Pyrrolidine and thiazole derivatives with antibacterial and metallo-beta-lactamase inhibitory properties
EP0247431A1 (de) Substituierte 6-Hydroxymethylcarbapenem-Antibiotika, Verfahren zu ihrer Herstellung und ihre Verwendung
AT395590B (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
EP0273747B1 (en) Penem derivatives, production and use thereof
JPS6033397B2 (ja) ペナム−１，１−ジオキシド
EP0362622B1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel
EP0210065A1 (en) 6-Alkylidene penems
US4591459A (en) Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides
NO841069L (no) Penicillansyre-derivater.
US4427678A (en) 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-lactamase inhibitors
EP0201221B1 (en) 6-(1-acyl-1-hydroxy methyl) penicillanic acid derivatives
US4540580A (en) 2-[(1'R)-1'-Aminoalkyl]penems
US4743598A (en) Antibacterial 2-(azacycloalkyl) penems
LU84739A1 (fr) Nouveaux antibiotiques de type carbapenem
IL141114A (en) Derivatives of carbapenem-3 carboxylic acids, their preparation and pharmaceutical preparations containing them
KR920002132B1 (ko) 항균성 2-카르바페넴 유도체
KR860001278B1 (ko) 베타-락타마제 저해제인 6-아미노 알킬페니실란산 1,1-디옥사이드 및 그의 유도체의 제조 방법